Clinical trial
VenaSeal Sapheon Closure System vs. Radiofrequency Ablation for Incompetent Greater Saphenous Veins
NCT01807585 is registered in ClinicalTrials.gov with Medtronic Endovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- VenaSeal Sapheon Closure System vs. Radiofrequency Ablation for Incompetent Greater Saphenous Veins
- Lead sponsor
- Medtronic Endovascular
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- April 10, 2017
- Enrollment
- 242 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
great saphenous vein (gsv) with venous reflux disease